Clinical Trial Update: Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial evaluated whether adding granulocyte colony-stimulating factor (G-CSF) to combination chemotherapy improves outcomes for patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Granulocyte Colony-Stimulating Factor (G-CSF) (G-CSF)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Endometrial Cancer | Phase 3 | Status: COMPLETED